Copellor 80mg Injection contains Ixekizumab 80mg, a prescription biologic medicine and selective #interleukin-17A (IL-17A) inhibitor. It is used to treat certain immune-mediated inflammatory conditions, including moderate-to-severe plaque #psoriasis and psoriatic #arthritis, as well as other approved inflammatory conditions depending on the patient’s age and local regulatory approval. #Taltz® is the reference brand containing #ixekizumab. #Copellor 80mg provides the same active ingredient, ixekizumab, and may be marketed as an alternative to Taltz® depending on the applicable regulatory classification.
